Novartis (Swiss: NOVN) announced the U.S. Food and Drug Administration approved a label update for Leqvio (inclisiran), allowing the drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE